Regardless of the sequential decrease in Current Liabilities, during the third quarter 2024, Quick Ratio deteriorated to 0.56 below Telesis Bio Inc 's average Quick Ratio.

Within Laboratory Analytical Instruments industry 19 other companies have achieved higher Quick Ratio than Telesis Bio Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 1768 to 2350.

Explain Quick Ratio?
How much Cash & cash equivalents TBIO�s has?
What are TBIO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TBIO Quick Ratio	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3
Y / Y Current Liabilities Change	-73.93 %	-22.85 %	-42.95 %	-39.37 %	-68.82 %
Y / Y Cash & cash equivalent Change	-78.61 %	-86.27 %	-54.52 %	-94.84 %	-97.39 %
Quick Ratio MRQ	0.56	0.8	1.66	0.19	0.68
TBIO's Total Ranking	# 2350	# 1768	# 1193	# 3338	# 1957
Seq. Current Liabilities Change	-17.28 %	24.97 %	-21.65 %	-67.8 %	144.74 %
Seq. Cash & cash equivalent Change	-41.85 %	-39.78 %	576.62 %	-90.97 %	-62.68 %

Quick Ratio third quarter 2024 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 20
Healthcare Sector	# 757
Overall Market	# 2350

Quick Ratio Statistics
High	Average	Low
13.55	4.38	0.19
(Sep 30 2018)		(Dec 31 2023)

Financial Statements
Telesis Bio Inc 's Current Liabilities	$ 7 Millions	Visit TBIO's Balance sheet
Telesis Bio Inc 's Cash & cash equivalent	$ 4 Millions	Visit TBIO's Balance sheet
Source of TBIO's Sales		Visit TBIO's Sales by Geography

Cumulative Telesis Bio Inc 's Quick Ratio

TBIO's Quick Ratio for the trailling 12 Months

TBIO Quick Ratio	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-51.71 %	-58.82 %	-77.53 %	-76.51 %	-82.48 %
Y / Y Cash & cash equivalent TTM Growth	-81.06 %	-95.31 %	-94.46 %	-95.57 %	-95.56 %
Quick Ratio TTM	0.76	0.75	1.51	1.61	1.95
Total Ranking TTM	# 3515	# 3386	# 3291	# 3422	# 3401
Seq. Current Liabilities TTM Growth	-39.13 %	-4.71 %	-8.74 %	-8.78 %	-48.09 %
Seq. Cash & cash equivalent TTM Growth	-38 %	-52.77 %	-14.32 %	-24.49 %	-84.66 %

Quick ratio ranking by company, industry and sector >> Back to TBIO Financial Strength Comparisons >> Go to Compare TBIO Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Telesis Bio Inc 's average Cash & cash equivalent, this led to increase in in Telesis Bio Inc 's Quick Ratio to 0.76, Quick Ratio remained below TBIO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 25 other companies have achieved higher Quick Ratio than Telesis Bio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 3386 to 3515.

Explain Quick Ratio?
How much Cash & cash equivalents TBIO�s has?
What are TBIO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 26
Healthcare Sector	# 943
Within the Market	# 3515

trailing twelve months Quick Ratio Statistics
High	Average	Low
8.89	4.46	0.37
(Sep 30 2019)		(Jun 30 2018)

Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2024 MRQ Cash & cash equivalent	Sep 30 2024 MRQ Current Liabilities
Prenetics Global Limited	1.43	$ 52.251 Millions	$ 36.551 Millions
Waters Corporation	1.30	$ 331.944 Millions	$ 255.329 Millions
Akoya Biosciences Inc	1.28	$ 35.896 Millions	$ 27.993 Millions
Lifeloc Technologies Inc	1.19	$ 0.842 Millions	$ 0.708 Millions
Accelerate Diagnostics Inc	1.15	$ 20.912 Millions	$ 18.258 Millions
Agilent Technologies inc	0.85	$ 1,329.000 Millions	$ 1,557.000 Millions
Kewaunee Scientific Corporation	0.81	$ 29.664 Millions	$ 36.471 Millions
Bionano Genomics Inc	0.70	$ 22.954 Millions	$ 32.950 Millions
Telesis Bio Inc	0.56	$ 3.720 Millions	$ 6.628 Millions
Illumina Inc	0.34	$ 70.000 Millions	$ 207.000 Millions
Precipio inc	0.27	$ 1.053 Millions	$ 3.888 Millions
Harvard Bioscience Inc	0.24	$ 4.569 Millions	$ 19.062 Millions
Avantor Inc	0.18	$ 285.300 Millions	$ 1,629.800 Millions

Date modified: 2026-09-26T07:40:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.